<DOC>
	<DOCNO>NCT01758809</DOCNO>
	<brief_summary>The purpose study evaluate whether pre-emptive local bupivacaine injection well alternative pain control modality conventional intravenous patient control analgesia .</brief_summary>
	<brief_title>Pain Control Thoracoscopic Major Pulmonary Resection</brief_title>
	<detailed_description>Despite less postoperative pain Video Assisted Thoracic Surgery ( VATS ) thoracotomy , pain still important issue recovery period . After VATS procedure , intravenous patient control analgesia ( IV PCA ) use pain control . However , side effect IV PCA nausea , vomit , sleepiness , urination difficulty interrupt early recovery . It establish pre-emptive local bupivacaine injection economical , almost side effect , finally , effective postoperative 24 hour . The purpose study evaluate whether pre-emptive local bupivacaine injection well alternative pain control modality conventional intravenous patient control analgesia .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>patient expect receive VATS segmenectomy lobectomy regardless disease entity do VATS anatomical resection patient agree study postoperative hospital stay exceed 7 day due postoperative complication existence preoperative renal insufficiency ( Cr &gt; 1.5 ) OT/PT &gt; 120 history Lidocaine hypersensitivity</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Video Assisted Thoracic Surgery</keyword>
	<keyword>Postoperative Pain</keyword>
	<keyword>Intravenous Patient Controlled Analgesia</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Major Pulmonary Resection</keyword>
	<keyword>Post Pulmonary Resection</keyword>
</DOC>